BriefCase vs Sepsis ImmunoScore
AI Verdict
Choose BriefCase if…
Choose BriefCase if your hospital or health system needs to enhance communication and collaboration specifically around critical medical imaging findings. This tool is ideal for streamlining the sharing of AI-detected abnormalities from radiology to the broader care team, ensuring urgent cases like intracranial hemorrhages or pulmonary embolisms are prioritized and acted upon quickly. It's particularly useful for reducing turnaround times in emergency departments and improving overall patient care coordination based on imaging results.
View BriefCase →Choose Sepsis ImmunoScore if…
Choose Sepsis ImmunoScore if your acute care setting requires an FDA-authorized AI diagnostic to rapidly assess sepsis risk and predict adverse patient outcomes. This tool is best suited for clinicians in emergency medicine, critical care, and hospital medicine who need to make faster, more precise treatment decisions by analyzing 22 EHR parameters to generate a sepsis risk score and categories. It can significantly improve the early diagnosis of sepsis and predict risks like in-hospital mortality, ICU admission, and length of stay within 24 hours.
View Sepsis ImmunoScore →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | BriefCase | Sepsis ImmunoScore |
|---|---|---|
| Pricing | Enterprise | Enterprise subscription model |
| Deployment | Cloud | Integrated into hospital EHR/EMR systems |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | 1 AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Sepsis ImmunoScoreSepsis ImmunoScore emphasizes an intuitive display that explains how each of the 22 parameters contributes to the risk score, fostering clinician trust and a true clinician-AI partnership. BriefCase, while integrated into the Aidoc platform and offering mobile access, focuses more on streamlining communication and collaboration rather than explicit transparency in its AI's decision-making process.
Clinical Value
Sepsis ImmunoScoreSepsis ImmunoScore is the first FDA-authorized AI diagnostic for sepsis, providing both diagnostic and prognostic power by predicting adverse outcomes like mortality, length of stay, and ICU admission within 24 hours. BriefCase, while FDA-cleared and demonstrating reduced overlooked cases of incidental pulmonary embolisms and intracranial hemorrhages, primarily functions as a triage and communication tool to expedite workflows.
Pricing & Value
TieBoth tools utilize an enterprise pricing model with custom quotes based on client needs, making direct cost comparison difficult. Aidoc's BriefCase has a baseline annual cost of approximately $50,000 per site, with additional module fees, and has received new technology add-on payments from Medicare for certain uses. Sepsis ImmunoScore's pricing is also an enterprise subscription model, with details varying by client size and needs, and is sold through a partnership with Roche Diagnostics.
Enterprise Readiness
BriefCaseAidoc's BriefCase is designed for large hospitals and health systems, with over 500 hospitals globally as customers, and offers seamless integration with PACS, RIS, and EHR systems. It also boasts a comprehensive set of compliance certifications including HIPAA, SOC2, and GDPR. BriefCase also has a mobile app available for both iOS and Android. Sepsis ImmunoScore is also integrated into hospital EHR/EMR systems and is HIPAA compliant, but specific customer count or mobile app availability is not detailed.
Innovation
Sepsis ImmunoScoreSepsis ImmunoScore is notable as the first FDA-authorized AI diagnostic for sepsis, leveraging 22 diverse parameters for a holistic patient evaluation and providing transparent explanations of its risk scores. Aidoc's BriefCase, while continuously expanding its FDA-cleared algorithm portfolio and recently securing clearance for a foundation-model-powered clinical AI device covering multiple indications, focuses on AI-driven communication and workflow optimization.
Support & Docs
TieBoth tools are enterprise-level solutions, implying dedicated support and comprehensive documentation. However, specific details regarding the nature, availability, or quality of their support and documentation are not explicitly provided in the given information or readily available through general web searches for a direct comparison.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | BriefCase | Sepsis ImmunoScore |
|---|---|---|
| Name | BriefCase | Sepsis ImmunoScore |
| Company | Aidoc Medical | Prenosis |
| Description | FDA-cleared AI-powered communication and collaboration solution integrated into the Aidoc platform, designed to streamline the sharing of critical medical imaging findings among care teams. | The first FDA-authorized AI diagnostic for sepsis, providing rapid risk assessment and prediction of adverse outcomes. It analyzes 22 parameters from EHRs to generate a risk score and four risk categories, aiding clinicians in faster treatment decisions and improved patient outcomes. |
| Target Size | Large hospitals and health systems | Not specified |
| Key Functionality | AI-driven critical finding detection (via Aidoc platform), Secure, real-time communication of findings, Customizable communication protocols, Automated follow-up tracking and reminders, Seamless integration with PACS, RIS, and EHR systems, Comprehensive audit trails for all communications, Prioritization of urgent cases for immediate attention, Mobile access for care team collaboration | First FDA-authorized AI diagnostic for sepsis, AI/ML Software as a Medical Device (SaMD), Guides rapid diagnosis and prediction of sepsis, Leverages 22 diverse parameters (biomarkers and clinical data), Outputs a risk score and four discrete risk categories, Predicts risk of deterioration (length of stay, in-hospital mortality, ICU admission, mechanical ventilation, vasopressor use) within 24 hours, Integrated directly into hospital Electronic Medical Records (EMR/EHR), Intuitive display explains how parameters contribute to the score (transparency) |
Videos
Demos, reviews, and walkthroughs featuring BriefCase and Sepsis ImmunoScore.